ArticleScientific reports2025
GENOMICON-Seq enables realistic simulation of amplicon and exome sequencing for low-frequency mutation detection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- bronko: ultrafast, alignment-free detection of viral genome variation.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate detection of low-frequency mutations is crucial for understanding viral evolution and tumorigenesis in humans, but is often confounded by technical artifacts introduced during library preparation and sequencing. We present GENOMICON-Seq, an end-to-end simulation tool that models both amplicon and whole exome sequencing (WES) workflows with realistic biological mutations and technical noise. GENOMICON-Seq inserts ground truth mutations, ranging from APOBEC3-like edits to COSMIC single base substitution signatures, before subjecting samples to simulated PCR errors, probe-capture enrichment, and Illumina-specific sequencing biases. By tracking each mutation's origin (true or error-derived), researchers can pinpoint detection limits and optimize variant-calling thresholds. We illustrate GENOMICON-Seq's versatility through study cases involving human papillomavirus (HPV) amplicon sequencing, highlighting the impacts of polymerase fidelity, viral copy number, and read depth on detecting low-frequency mutations. In parallel, WES simulations demonstrate how capture biases and varying allele frequencies affect somatic mutation calls. GENOMICON-Seq is thus a flexible, reproducible framework for assessing new protocols, benchmarking variant callers, and refining data analysis pipelines, ultimately reducing costly trial-and-error in the laboratory. The Docker-based package is freely available at https://github.com/Rounge-lab/GENOMICON-Seq .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.